Advertisement
For patients with metastatic renal cell carcinoma

Atezolizumab + Bevacizumab Shows Benefit in Met Renal CA

0
Progression-free survival benefit for patients with untreated metastatic renal cell carcinoma
Good regional control can be achieved with up-front surgery and adjuvant therapy for patients with invasive nodal disease from oropharyngeal squamous cell carcinoma related to human papillomavirus

Approach Offers Regional Control of HPV-Related Head, Neck CA

0
Surgery and adjuvant therapy used for invasive nodal disease requiring extensive neck dissection
Health care consumers have four major concerns regarding their physicians

Top Consumer Concerns Reported About Physicians

0
Concerns relate to time with physicians; technology detracting from patient care; rising costs
A long-feared shortage of a substance used in millions of medical imaging procedures each year in the United States appears to have been avoided

FDA Says U.S. Will Now Produce Critical MRI Component

0
New technology approved to produce the country's own supply of the radioisotope Technetium-99m
For patients with non-muscle invasive bladder cancer

Active Surveillance OK for Non-Muscle Invasive Bladder Cancer

0
Appears to be a cost-effective strategy for patients with small size, stage pTa or pT1a recurrent tumors
Most people do not believe that professionals including health care providers should be allowed to refuse to provide services based on their conscience or beliefs

Poll: Personal Beliefs Shouldn’t Allow Doctors to Refuse to Treat

0
Majority surveyed don't believe health care workers should be able to refuse services based on beliefs
For men with non-metastatic castration-resistant prostate cancer

Apalutamide Active in Castration-Resistant Prostate Cancer

0
Apalutamide prolongs metastasis-free survival in non-metastatic castration-resistant prostate cancer
High detection rates of high-grade ductal carcinoma in situ (DCIS) persist in consecutive subsequent screening rounds versus the prevalence round

High Detection Rates of High-Grade DCIS Persist

0
Low-, intermediate-grade DCIS less frequently ID'd in subsequent screening rounds vs. prevalence round
The amount of U.S. health care resources devoted to treating obesity-related illness in U.S. adults rose 29 percent from 2001 to 2015

Expenditures Rising for Treating Obesity-Related Illness in U.S.

0
Proportion of medical expenditures for obesity-related illness varies widely by state
The prevalence of human papillomavirus (HPV) and of high-risk HPV type 16 or 18 is 4.9 and 3.9 percent

HPV Prevalence 4.9 Percent in Tonsil Tissue of Healthy Adults

0
Human papillomavirus colocalizes to the biofilm of the tonsillar crypts